C-reactive protein in the very early phase of acute ischemic stroke: Association with poor outcome and death

Journal of Neurology

Volumn 256, Issue 12, 2009, Pages 2003-2008

  Den Hertog, H M ^a   Van Rossum, J A ^a   Van Der Worp, H B ^b   Van Gemert, H M A ^c   De Jonge, R ^a   Koudstaal, P J ^a   Dippel, D W J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c MEANDER MEDICAL CENTER   (Netherlands)

Author keywords

C reactive protein; Clinical outcome; Inflammation; Ischemic stroke; Prognostic factor

Indexed keywords

ALTEPLASE; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PARACETAMOL;

ACUTE DISEASE; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CIGARETTE SMOKING; CLINICAL TRIAL; DEATH; DIABETES MELLITUS; DRUG UTILIZATION; EMBOLISM; FEMALE; FUNCTIONAL ASSESSMENT; GENDER; HEART ATRIUM FIBRILLATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INFECTION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RANKIN SCALE; RECTUM TEMPERATURE; RISK ASSESSMENT; SCORING SYSTEM; TYMPANIC TEMPERATURE;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BRAIN ISCHEMIA; C-REACTIVE PROTEIN; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; RISK FACTORS; STROKE;

EID: 71849109771     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-009-5228-x     Document Type: Article

References (30)

1. HP Adams BH Bendixen LJ Kappelle, et al. 1993 Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment Stroke 24 35 41 7678184
2. MA Albert E Danielson N Rifai, et al. 2001 Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study JAMA 286 64 70 10.1001/jama.286.1.64 1:CAS:528:DC%2BD3MXltleit74%3D 11434828
3. S Aslanyan CJ Weir HC Diener, et al. 2004 Pneumonia and urinary tract infection after acute ischaemic stroke: a tertiary analysis of the GAIN International trial Eur J Neurol 11 49 53 10.1046/j.1468-1331.2003.00749.x 1:STN:280:DC%2BD2c%2Fms1Gktw%3D%3D 14692888 (Pubitemid 38174922)
4. FC Barone GZ Feuerstein 1999 Inflammatory mediators and stroke: new opportunities for novel therapeutics J Cereb Blood Flow Metab 19 819 834 10.1097/00004647-199908000-00001 1:CAS:528:DC%2BD3cXksFSktbk%3D 10458589
5. T Brott HP Adams CP Olinger, et al. 1989 Measurements of acute cerebral infarction: a clinical examination scale Stroke 20 864 870 1:STN:280: DyaL1MzhvVequg%3D%3D 2749846 (Pubitemid 19188240)
6. H Christensen G Boysen 2004 C-reactive protein and white blood cell count increases in the first 24 h after acute stroke Cerebrovasc Dis 18 214 219 10.1159/000079944 1:CAS:528:DC%2BD2cXnsFWjtb8%3D 15273437 (Pubitemid 39279396)
7. HM den Hertog HB van der Worp HM van Gemert, et al. 2008 Correction: PAIS: paracetamol (acetaminophen) in stroke; protocol for a randomized, double blind clinical trial. [ISCRTN74418480] BMC Cardiovasc Disord 8 29 10.1186/1471-2261-8-29 18983661
8. M Di Napoli F Papa V Bocola 2001 C-reactive protein in ischemic stroke: an independent prognostic factor Stroke 32 917 924 1:STN:280: DC%2BD3M3ivVyqsg%3D%3D 11283392 (Pubitemid 32285161)
9. M Di Napoli F Papa V Bocola 2001 Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke Stroke 32 133 138 1:CAS:528:DC%2BD3MXhtFKhsrs%3D 11136928 (Pubitemid 32063837)
10. M Di Napoli M Schwaninger R Cappelli, et al. 2005 Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: a statement for health care professionals from the CRP Pooling Project members Stroke 36 1316 1329 10.1161/01.STR.0000165929.78756.ed 1:CAS:528:DC%2BD2MXksVWrsLY%3D 15879341 (Pubitemid 40798763)
11. HC Emsley SJ Hopkins 2008 Acute ischemic stroke and infection: recent and emerging concepts Lancet Neurol 7 341 353 10.1016/S1474-4422(08)70061-9 18339349
12. HC Emsley CJ Smith CM Gavin, et al. 2003 An early and sustained peripheral inflammatory response in acute ischemic stroke: relationships with infection and atherosclerosis J Neuroimmunol 139 93 101 10.1016/S0165-5728(03) 00134-6 1:CAS:528:DC%2BD3sXksVOlsrw%3D 12799026 (Pubitemid 36694395)
13. R Gill JA Kemp C Sabin MB Pepys 2004 Human C-reactive protein increases cerebral infarct size after middle cerebral artery occlusion in adult rats J Cereb Blood Flow Metab 24 1214 1218 10.1097/01.WCB.0000136517.61642.99 1:CAS:528:DC%2BD2cXptl2gtrY%3D 15545914 (Pubitemid 39482482)
14. M Griselli J Herbert WL Hutchinson, et al. 1999 C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction J Exp Med 190 1733 1740 10.1084/jem.190.12.1733 1:CAS:528: DC%2BD3cXitleg 10601349 (Pubitemid 30013840)
15. A Kocer C Canbulat E Gozke, et al. 2005 C-reactive protein is an indicator for fatal outcomes in first-time stroke patients Med Sci Monit 11 CR540 CR544 1:CAS:528:DC%2BD2MXhtlWgtrrP 16258400
16. I Kushner A Agrawal 2007 CRP can play both pro-inflammatory and anti-inflammatory roles Mol Immunol 44 670 671 10.1016/j.molimm.2006.02.001 1:CAS:528:DC%2BD28Xos12lsro%3D 16540170 (Pubitemid 44287041)
17. C Ladenvall K Jood C Blomstrand, et al. 2006 Serum C-reactive protein concentration and genotype in relation to ischemic stroke subtype Stroke 37 2018 2023 10.1161/01.STR.0000231872.86071.68 1:CAS:528:DC%2BD28XmvFaksrY%3D 16809555 (Pubitemid 44309897)
18. L Masotti E Ceccarelli S Forconi, et al. 2005 Prognostic role of C-reactive protein in very old patients with acute ischaemic stroke J Intern Med 258 145 152 10.1111/j.1365-2796.2005.01514.x 1:CAS:528:DC%2BD2MXpsVamurg%3D 16018791 (Pubitemid 41025971)
19. BW McColl SM Allan NJ Rothwell 2007 Systemic inflammation and stroke: aetiology, pathology and targets for therapy Biochem Soc Trans 35 1163 1165 10.1042/BST0351163 1:CAS:528:DC%2BD2sXht1eru7vJ 17956302 (Pubitemid 350206451)
20. J Montaner I Fernandez-Cadenas CA Molina, et al. 2006 Poststroke C-reactive protein is a powerful prognostic tool among candidates for thrombolysis Stroke 37 1205 1210 10.1161/01.STR.0000217744.89208.4e 1:CAS:528:DC%2BD28XjsFahtrk%3D 16601211 (Pubitemid 43731863)
21. KW Muir CJ Weir W Alwan, et al. 1999 C-reactive protein and outcome after ischemic stroke Stroke 30 981 985 1:STN:280:DyaK1M3kvVeitQ%3D%3D 10229731
22. MB Pepys GM Hirschfield GA Tennent, et al. 2006 Targeting C-reactive protein for the treatment of cardiovascular disease Nature 440 1217 1221 10.1038/nature04672 1:CAS:528:DC%2BD28XjvVGltLY%3D 16642000
23. PM Ridker E Danielson FA Fonseca, et al. 2008 Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein N Engl J Med 359 2195 2207 10.1056/NEJMoa0807646 1:CAS:528:DC%2BD1cXhtl2gurnL 18997196
24. PM Ridker N Rifai MA Pfeffer, et al. 1999 Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators Circulation 100 230 235 1:CAS:528:DyaK1MXltVOhtrc%3D 10411845
25. CJ Smith HC Emsley CM Gavin, et al. 2004 Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome BMC Neurol 4 2 10.1186/1471-2377-4-2 14725719 (Pubitemid 38729102)
26. CJ Smith HC Emsley A Vail, et al. 2006 Variability of the systemic acute phase response after ischemic stroke J Neurol Sci 251 77 81 10.1016/j.jns.2006. 09.011 1:CAS:528:DC%2BD28Xht1Chs73L 17087970 (Pubitemid 44792143)
27. R Topakian AM Strasak K Nussbaumer, et al. 2008 Prognostic value of admission C-reactive protein in stroke patients undergoing iv thrombolysis J Neurol 255 1190 1196 10.1007/s00415-008-0866-y 1:CAS:528:DC%2BD1cXhtFOrur%2FO 18484234
28. EJ van Breda HB van der Worp HM van Gemert, et al. 2005 PAIS: paracetamol (acetaminophen) in stroke; protocol for a randomized, double blind clinical trial [ISRCTN 74418480] BMC Cardiovasc Disord 5 24 10.1186/1471-2261-5-24 16109181 (Pubitemid 41461219)
29. JC van Swieten PJ Koudstaal MC Visser, et al. 1988 Interobserver agreement for the assessment of handicap in stroke patients Stroke 19 604 607 3363593
30. K Winbeck H Poppert T Etgen, et al. 2002 Prognostic relevance of early serial C-reactive protein measurements after first ischemic stroke Stroke 33 2459 2464 10.1161/01.STR.0000029828.51413.82 1:CAS:528:DC%2BD38Xntlanu7k%3D 12364738